Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
28 December 2021 - 8:01AM
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage
regenerative medicine company focused on creating the next
generation of differentiated products and improving outcomes in
patients undergoing surgery, today announced that members of
management will present at the upcoming H.C. Wainwright Bioconnect
Virtual Conference.
A Pre-recorded presentation will be available on
Monday, January 10th at 7:00 am Eastern Time. Interested parties
may access a webcast of the presentation on the investor section of
the Company’s website at www.Aziyo.com
About Aziyo Biologics Aziyo Biologics is a
commercial-stage regenerative medicine company focused on creating
the next generation of differentiated products and improving
outcomes in patients undergoing surgery, concentrating on patients
receiving implantable medical devices. Since its founding in 2015,
the Company has created a portfolio of commercial-stage products
used in cardiovascular, orthopedic, and reconstructive specialties.
For more information, visit
www.Aziyo.com.
Media:Courtney GuyerAziyo Biologics,
Inc.PR@aziyo.com
Investors:Leigh Salvo Gilmartin
Groupinvestors@aziyo.com
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Apr 2023 to Apr 2024